RNS Number : 8674N ConvaTec Group PLC 11 May 2018

CONVATEC GROUP PLC - AGM

11 MAY 2018 - CORRECTED POLL RESULT

Result of Meeting

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below. The number of votes withheld has been corrected and a column of number of votes cast included.

  • 1 Receive Annual Report and Accounts

  • 2 Approve the Directors' Remuneration Report

  • 3 Declare Final Dividend

  • 4 Re-elect Sir Christopher Gent as a Director

  • 5 Re-elect Paul Moraviec as a Director

  • 6 Elect Frank Schulkes as a Director

  • 7 Re-elect Steve Holliday as a Director

  • 8 Re-elect Jesper Ovesen as a Director

  • 9 Re-elect Rick Anderson as a Director

  • 10 Re-elect Kasim Kutay as a Director

  • 11 Elect Ros Rivaz as a Director

  • 12 Elect Regina Benjamin as a Director

  • 13 Elect Margaret Ew ing as a Director

  • 14 Re-appoint Deloitte LLP as auditors

  • 15 Authorise the Directors to agree the auditors'

1,483,108,674

1,488,939,928

1,481,688,827

1,482,717,535

1,476,891,196

1,488,985,560

1,488,564,111

1,486,522,754

remuneration

  • 16 Authorise allotment of shares

    1,479,661,716

    99.25 11,131,674 0.75

    633,119

    1,490,793,390

    76.38%

  • 17 Disapply pre-emption rights*

  • 18 Disapply pre-emption rights in connection w ith an acquisition or specified capital investment*

  • 19 Authorise purchase of ow n shares*

    1,485,284,913

    99.75

    3,698,352

    0.25 2,443,243 1,488,983,265

    76.29%

  • 20 Authorise political donations and political expenditure

  • 21 Call general meetings on 14 days' notice*

*Special Resolution

NOTES:

  • 1. All resolutions were passed.

  • 2. Votes "For" and "Against" are expressed as a percentage of votes received.

  • 3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

  • 4. Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares. Up to 76.39% of voting capital was instructed.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.www.convatecgroup.com

This information is provided by RNS

The company news service from the London Stock Exchange

Enquiries

Analysts and Investors

John Crosse, VP Investor Relations

+44 (0)7500 141 435

Kirsty Law, Director Investor Relations

+44 (0)7470 909 582

investorrelations@convatec.com

Media

Bobby Leach, VP Group Corporate Affairs

+44 (0)7770 842 226

Finsbury

+44 (0)207 251 3801

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

###

END

This information is provided by RNS

The company news service from the London Stock Exchange

END

AGMSFDFLFFASEEI

Attachments

  • Original document
  • Permalink

Disclaimer

ConvaTec Group plc published this content on 11 May 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 May 2018 14:37:01 UTC